Advertisement
This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
OK
Dublin: 9 °C Friday 16 November, 2018

Comment #7162962 by Ciara Forsey

Ciara Forsey Apr 30th 2018, 8:38 AM #

Dear Mr Ant McPartlin,

I have been reading about the battle that you are having with Fentanyl and I am amazed that nobody has suggested that you be treated with the OLANI.

As that you are now out of rehab, now is a perfect time to get this sorted once and for all.

Please take the time to read this letter and see that this treatment, whether it be done in The Bahamas, Australia or UK, will sort out your addiction and fast, so you can get back to work making everybody laugh on Britain’s Got Talent.

It is with some pride that we announce the availability to United States residents, for the first time, of the O’Neil Long Acting Naltrexone Implant or “OLANI”, from Australian addiction expert, DR. GEORGE O’NEIL, at our America’s base in the Bahamas.

Dr O’Neil’s implant is a break-through product. It is substantially longer acting – plus or minus a year typically – and it delivers a more constant flow of naltrexone than contenders made in Europe, Asia and the United States.

In clinical trials undertaken in Australia, more than 90% of opiate addicts were clean after 9 months, and more than 60% of alcoholics were not drinking at all after 6 months, with the remainder drinking only one or two drinks at a sitting.

These results are dramatically better than those achieved by any other protocol available in the States and very substantially better than even those achieved with ibogaine, which used to be our favoured modality.

Clinical trials leading to FDA Approval in the United States were agreed in July 2017, with one of it’s most prestigious research institutions.

Forms of approval for the OLANI have already been established in Australia, the United Kingdom, Ireland, The Netherlands and The Bahamas.

OUR PHILOSOPHY

We know about opiates and opioids.

Once someone has experienced the extraordinary power of opiates to address pain issues, be they physical or psychological, there exists no way back. It is a knowledge that can never be unlearned.
The road from addiction to sobriety is hard and long, where the road in the opposite direction is short, easy and increasingly deadly.
Maintenance drugs, in particular, buprenorphine, have some advantages over street opiates when it comes to overdose risk. But they are the same in terms of side effects – chronic constipation, sexual dysfunction, heavy withdrawals and so on; also they leave an individual firmly positioned in the opiate world, where oxycodone and heroin still rule.

Against this background, we have for some years been excited by the potential value of naltrexone. Naltrexone is a full opiate antagonist, meaning it completely blocks the effects of opiates, and opioids. It also has proven extremely helpful for those with alcohol issues. It is approved by the FDA in oral (Revia) and injectable (Vivitrol) forms for opiate and alcohol applications.

Currently, there are a number of naltrexone delivery possibilities available in the United States, but none of them operates in full action for more than two months – it’s not enough!

The OLANI changes that dynamic completely……….

The O’Neil Long Acting Naltrexone Implant
Was developed in response to problems associated with patients failing to take oral naltrexone regularly. To date, it has been used in over 11000 people including opiate, opioid, alcohol, cocaine, methamphetamine and polydrug abusers. The implants are placed under the skin via a small cut below the belt line, done under local anaesthetic. As the implant breaks down naltrexone is released into the body for a period of up to 12 months. Research comparing overdose mortality rates in oral and implant patients has shown that implants are vastly superior, at 17,22 deaths per thousand patient years for those who take orally compared with 0.67 deaths per thousand patient years for those with implants.
Dr George O’Neil
Recognized some while ago that in Australia, like the United States, there are only two common treatments available for people wishing to be free of opiate addictions. One involves the use of methadone or buprenorphine, drugs which help people manage their addiction through a regular dose of a synthetic opioid. The other is to ask people to go ‘cold turkey’, to abstain. Like us, he wasn’t comfortable with either approach. And that’s when he started his work with blockers, of which Naltrexone is one.
Naltrexone provides opiate relapse prevention by binding to the opiate receptors and blocking opiates such as heroin from having an effect. Cravings are greatly reduced and use becomes unfulfilling as its pleasurable aspects are blocked. By blocking opiate receptors, naltrexone also reduces dopamine ‘spikes’. Dopamine is a neurotransmitter that is involved in reward. By reducing dopamine, the positive reward associated with using stimulants, like cocaine or methamphetamine, or alcohol, is also reduced, and so it becomes a form of relapse prevention for them too.
When Dr O’Neil began his search for alternatives the only form of naltrexone available was the daily dose. It worked well in blocking but was ineffective in preventing a relapse because it was too easy to simply quit. Experimentation with implants had already begun in Russia, but the technology which they were using, and still are, only makes possible the manufacture of 60-day implants. The US uses the same technology with similar outcomes.
Working with the same polymers used to make biodegradable surgical screws Dr O’Neil made an implant that offers a much steadier dose for 5 times as long. Since its introduction, it has been constantly modified, and now the OLANI provides unquestionably the best implant available anywhere.
OPIATES
Dr O Neil developed the OLANI specifically to help addicts after detoxification from opiates.Overcoming withdrawals, however, achieved, is always a difficult process, but staying clean has proved infinitely harder.

The majority of people leaving traditional rehabilitation clinics in the United States remain drug-free for less than a month. Other therapies offer better results, but not much.

Addiction experts agree on one thing. That a period of 9 to 12 months drug-free is the minimum time required to rebuild physically and mentally and to have a real chance of lasting sobriety.

This includes clinics that provide other shorter-acting naltrexone delivery vehicles, who recommend multiple doses and the very real risk of noncompliance.

The OLANI offers genuine long-lasting protection from making a mistake. It gives recovering addicts a second chance and a third chance………….A real opportunity to get it right.

The OLANI also offers peace of mind, especially to those who have a close relationship with a recovering addict, by providing protection from overdose death for up to a year.

Kind Regards,

Paul.

Reply
| Share | Report this comment

Read the article where this comment appeared:

'I'm truly sorry': Ant McPartlin apologises for drink-driving crash

'I'm truly sorry': Ant McPartlin apologises for drink-driving crash

The presenter has been banned from driving for 20 months and received a fine of €99,500.

REPLIES

Leave a commentcancel